Virtu Financial’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.05M | Sell |
37,376
-439,831
| -92% | -$11.7M | 0.04% | 292 |
|
|
2025
Q4 | $11.9M | Buy |
477,207
+222,761
| +88% | +$5.62M | 0.46% | 12 |
|
|
2025
Q3 | $6.48M | Buy |
+254,446
| New | +$6.28M | 0.36% | 44 |
|
|
2025
Q2 | – | Sell |
-242,292
| Closed | -$6.14M | – | 1911 |
|
|
2025
Q1 | $6.14M | Buy |
242,292
+71,102
| +42% | +$1.86M | 0.33% | 28 |
|
|
2024
Q4 | $4.54M | Buy |
171,190
+119,407
| +231% | +$3.24M | 0.24% | 66 |
|
|
2024
Q3 | $1.5M | Buy |
+51,783
| New | +$1.51M | 0.08% | 188 |
|
|
2024
Q2 | – | Sell |
-227,547
| Closed | -$6.31M | – | 1751 |
|
|
2024
Q1 | $6.31M | Sell |
227,547
-43,963
| -16% | -$1.22M | 0.48% | 22 |
|
|
2023
Q4 | $7.82M | Buy |
+271,510
| New | +$8.21M | 0.62% | 13 |
|
|
2023
Q3 | – | Sell |
-245,994
| Closed | -$9.02M | – | 1744 |
|
|
2023
Q2 | $9.02M | Buy |
245,994
+181,007
| +279% | +$7.05M | 0.69% | 13 |
|
|
2023
Q1 | $2.65M | Buy |
64,987
+44,990
| +225% | +$1.94M | 0.28% | 65 |
|
|
2022
Q4 | $1.02M | Sell |
19,997
-50,529
| -72% | -$2.42M | 0.14% | 131 |
|
|
2022
Q3 | $3.09M | Buy |
70,526
+62,860
| +820% | +$3.05M | 0.28% | 57 |
|
|
2022
Q2 | $402K | Sell |
7,666
-3,051
| -28% | -$155K | 0.03% | 454 |
|
|
2022
Q1 | $555K | Buy |
+10,717
| New | +$556K | 0.04% | 357 |
|
|
2021
Q4 | – | Sell |
-94,565
| Closed | -$4.07M | – | 2068 |
|
|
2021
Q3 | $4.07M | Buy |
+94,565
| New | +$4.19M | 0.36% | 30 |
|
|
2021
Q2 | – | Sell |
-32,692
| Closed | -$1.18M | – | 1940 |
|
|
2021
Q1 | $1.18M | Buy |
+32,692
| New | +$1.16M | 0.08% | 207 |
|
|
2019
Q4 | $541K | Sell |
14,547
-22,474
| -61% | -$801K | 0.05% | 384 |
|
|
2019
Q3 | $1.26M | Buy |
37,021
+19,225
| +108% | +$699K | 0.1% | 221 |
|
|
2019
Q2 | $732K | Buy |
17,796
+2,547
| +17% | +$101K | 0.04% | 392 |
|
|
2019
Q1 | $614K | Buy |
15,249
+3,916
| +35% | +$157K | 0.03% | 481 |
|
|
2018
Q4 | $469K | Sell |
11,333
-88,130
| -89% | -$3.66M | 0.03% | 520 |
|
|
2018
Q3 | $4.16M | Buy |
99,463
+6,924
| +7% | +$267K | 0.25% | 62 |
|
|
2018
Q2 | $3.19M | Buy |
+92,539
| New | +$3.16M | 0.19% | 74 |
|
|
2018
Q1 | – | Sell |
-32,783
| Closed | -$1.13M | – | 2430 |
|
|
2017
Q4 | $1.13M | Buy |
+32,783
| New | +$1.12M | 0.06% | 390 |
|
|
2017
Q3 | – | Sell |
-12,208
| Closed | -$389K | – | 2495 |
|
|
2017
Q2 | $389K | Sell |
12,208
-3,314
| -21% | -$105K | 0.05% | 243 |
|
|
2017
Q1 | $504K | Sell |
15,522
-78,050
| -83% | -$2.46M | 0.05% | 223 |
|
|
2016
Q4 | $2.88M | Buy |
+93,572
| New | +$2.86M | 0.31% | 52 |
|
|
2016
Q3 | – | Sell |
-32,623
| Closed | -$1.09M | – | 475 |
|
|
2016
Q2 | $1.09M | Buy |
+32,623
| New | +$1.04M | 0.15% | 135 |
|
|
2016
Q1 | – | Sell |
-17,334
| Closed | -$531K | – | 484 |
|
|
2015
Q4 | $531K | Buy |
+17,334
| New | +$545K | 0.08% | 222 |
|
|
2015
Q1 | – | Sell |
-8,534
| Closed | -$252K | – | 361 |
|
|
2014
Q4 | $252K | Buy |
+8,534
| New | +$245K | 0.03% | 261 |
|
|
2014
Q2 | – | Sell |
-16,390
| Closed | -$499K | – | 422 |
|
|
2014
Q1 | $499K | Buy |
+16,390
| New | +$489K | 0.07% | 208 |
|
Other funds holding PFE
VCM
VPM
Virtu Financial's PFE Position: Q1 2026 in Review
Virtu Financial reduced its Pfizer (PFE) stake by 92% in Q1 2026, selling an estimated $11.7M and leaving 37,376 shares worth $1.05M. The position accounts for 0.04% of the portfolio, ranked #292.
Virtu Financial first reported a position in PFE in Q1 2014 and has held it in 31 quarters since. The position peaked at $11.9M in Q4 2025. 2,946 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Virtu Financial held 37,376 shares of Pfizer worth $1.05M as of Q1 2026.
- Virtu Financial sold 439,831 Pfizer shares in Q1 2026, an estimated $11.7M.
- Pfizer made up 0.04% of Virtu Financial's portfolio in Q1 2026, its #292 holding.
- Virtu Financial first reported a position in Pfizer in Q1 2014 and has held it in 31 quarters since.
- Virtu Financial's Pfizer position peaked at $11.9M in Q4 2025.
- 2,946 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.